Genomic Valley Biotech Ltd
GVBLGenomic Valley Biotech Ltd
GVBL
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 40.55 | 2.30 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 43.68 | 5.01 | 0.72% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Genomic Valley Biotech Ltd is conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market
Peers
Compare with peersBiocon Ltd
Hester Biosciences Ltd
Panacea Biotec Ltd
Zenotech Laboratories Ltd
Transgene Biotek Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.10 | 0.27 | 0.52 | 0.62 | 1.00 | 0.86 | 0.21 | 0.57 | 2.76 | 1.85 | ||||||||||
Raw Materials | 0.01 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.58 | 1.66 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.04 | 0.01 | 0.01 | 0.05 | 0.02 | 0.00 | 0.01 | 0.00 | |||||||||||
| Employee Cost | 0.03 | 0.13 | 0.25 | 0.34 | 0.27 | 0.18 | 0.09 | 0.14 | 0.15 | |||||||||||
| Selling & Administrative Expenses | 0.03 | 0.25 | 0.10 | 0.09 | 0.14 | 0.09 | 0.08 | 0.13 | 0.09 | |||||||||||
| Operating & Other expenses | 0.01 | 0.06 | 0.18 | 0.05 | 0.11 | -0.00 | 0.18 | 0.17 | 0.28 | |||||||||||
EBITDA | 0.02 | -0.28 | -0.02 | 0.13 | 0.43 | 0.57 | -0.14 | 0.12 | 0.66 | 0.19 | ||||||||||
| Depreciation/Amortization | 0.01 | 0.05 | 0.04 | 0.08 | 0.19 | 0.18 | 0.19 | 0.08 | 0.01 | -0.01 | ||||||||||
| PBIT | 0.01 | -0.33 | -0.06 | 0.05 | 0.24 | 0.39 | -0.33 | 0.04 | 0.65 | 0.20 | ||||||||||
| Interest & Other Items | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.18 | 0.18 | 0.04 | 0.00 | — | ||||||||||
| PBT | -0.02 | -0.35 | -0.06 | 0.05 | 0.24 | 0.21 | -0.51 | 0.00 | 0.65 | 0.20 | ||||||||||
| Taxes & Other Items | 0.00 | -0.01 | 0.00 | 0.02 | 0.00 | -0.08 | 0.06 | 0.01 | 0.00 | — | ||||||||||
| Net Income | -0.02 | -0.34 | -0.06 | 0.03 | 0.24 | 0.29 | -0.57 | -0.01 | 0.65 | 0.20 | ||||||||||
| EPS | -0.07 | -1.11 | -0.20 | 0.10 | 0.79 | 0.95 | -1.87 | -0.03 | 2.13 | 0.65 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CareBiotechnology
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Genomic Valley Biotech Ltd | 12.48 | 2.30 | — |
| Biocon Ltd | 61.19 | 1.26 | 0.64% |
| Hester Biosciences Ltd | 48.37 | 4.46 | 0.53% |
| Panacea Biotec Ltd | -29.26 | 1.16 | — |
Price Comparison
Compare GVBL with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 2.44%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
GVBL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Genomic Valley Biotech reports standalone net profit of Rs 0.06 crore in the September 2022 quarter
1 year ago•Business Standard
Genomic Valley Biotech reports standalone net profit of Rs 0.01 crore in the December 2021 quarter
1 year ago•Business Standard
Genomic Valley Biotech reports standalone net loss of Rs 0.11 crore in the June 2021 quarter
2 years ago•Business Standard
Genomic Valley Biotech reports standalone net loss of Rs 0.38 crore in the March 2021 quarter
2 years ago•Business Standard
Genomic Valley Biotech reports standalone net loss of Rs 0.01 crore in the December 2020 quarter
2 years ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 34.8%, vs industry avg of 19.45%
Increasing Market Share
Over the last 5 years, market share increased from 0.01% to 0.02%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 84.99%, vs industry avg of 8.68%